معرفی
Gerard Koppelman is a Full Professor of Pediatric Pulmonology at the University of Groningen, affiliated with the Faculty of Medical Sciences and the Groningen Research Institute of Asthma and COPD (GRIAC). He holds leadership roles as Head of the Department of Pediatric Pulmonology and Pediatric Allergology at the University Medical Center Groningen (UMCG). His clinical practice focuses on children with severe chronic lung diseases, while his research emphasizes genetics, epigenetics, and environmental factors influencing asthma and atopy. Key achievements include identifying novel asthma-related genes and epigenetic signatures in childhood asthma.
**Education**: MD (cum laude) from University of Groningen (1996), PhD in Medical Sciences (cum laude) on asthma genetics (2001). Career highlights include tenure-track positions, Visiting Associate Professorships at Harvard Medical School, and leadership roles in global research consortia.
**Research Focus**: Diagnostic DNA tests, early asthma biomarkers, gene function studies in cellular/animal models. Collaborates closely with patients and industry (e.g., AstraZeneca). Founded exquAIro, leveraging AI for health innovation.
**Awards & Roles**: Vici Grant (2022), Editorial Board member of *Allergy* and *American Journal of Respiratory and Critical Care Medicine*, Ambassador for Open Access at University of Groningen.
**Grants & Students**: Supervises 9 PhD students. Recent grants include funding for long-term lung function studies and AI-driven allergy diagnosis algorithms. Media highlights include breakthroughs in DNA-based allergy detection and asthma treatment optimization.
